By Cara Salvatore ( November 14, 2016, 8:25 PM EST) -- Merck & Co. and two other drugmakers urged the Ninth Circuit on Thursday not to revive a whistleblower suit accusing pharmaceutical companies of violating the False Claims Act by paying kickbacks related to a blood-thinning drug, saying the courts don't have jurisdiction because of prior public information....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.